NOVANT MEDICAL GROUP INCPub 78
Pub 78
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2023 (Year End)
$463,714,205
Other Assets
46%
Receivables (Non-Related)
34%
Property, Plant, & Equipment (net)
19%
Cash & Equivalents
<1%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Investments
0%
Liabilities in 2023 (Year End)
$2,096,695,733
Other Liabilities
94%
Payables & Accruals
6%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$4,592,386
$0
-100%
Receivables (Non-Related)
$157,134,852
$0
-100%
Related-Party Receivables
-
$0
-
Inventories
-
$0
-
Prepaid Expenses
$1,056,824
$0
-100%
Investments
-
$0
-
Property, Plant, & Equipment (net)
$88,010,397
$0
-100%
Other Assets
$212,919,746
$0
-100%
Total Assets
$463,714,205
$0
-100%
Liabilities
2023
2024
Change
Payables & Accruals
$135,329,219
-
-
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$1,961,366,514
-
-
Total Liabilities
$2,096,695,733
$0
-100%
Net assets
2023
2024
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
-$1,632,981,528
$0
-100%
Net assets
2023
2024
Change
Net assets
-$1,632,981,528
+$0
-100%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)